Desoxycorticosterone pivalate
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Trade names | Zycortal, Percorten V, Percorten M, Neocortin Depositum, Neocortodina Depositum, Neodin Depositum |
| Other names | DOCP; Deoxycorticosterone pivalate; Desoxycortone pivalate; Deoxycortone pivalate; Percoten pivalate; Desoxycorticosterone trimethylacetate; Desoxycorticosterone trimethyl acetate; DCT; DOC-TMA; SC-46312; 21-Hydroxypregn-4-ene-3,20-dione pivalate; 21-(2,2-Dimethyl-1-oxopropoxy)pregn-4-ene-3,20-dione |
| Routes of administration |
Intramuscular injection |
| Drug class | Corticosteroid; Mineralocorticoid |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.011.242 |
| Chemical and physical data | |
| Formula | C26H38O4 |
| Molar mass | 414.586 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Deoxycorticosterone pivalate (DOCP), also known as desoxycorticosterone trimethyl acetate (DOC-TMA or DCT) and sold under the brand names Zycortal, Percorten V, and Percorten M, is a mineralocorticoid medication and a mineralocorticoid ester. It is formulated as a microcrystalline aqueous suspension, is administered by intramuscular injection at regular intervals, and has a prolonged duration of action. The medication is the C21 pivalate (trimethylacetate) ester of 11-deoxycorticosterone.
See also
| Mineralocorticoids | |
|---|---|
| Antimineralocorticoids | |
| Synthesis modifiers | |
| |
| PR |
|
||||||
|---|---|---|---|---|---|---|---|
|
mPR (PAQR) |
|
||||||